Patent ID: 9402952
Filing Date: 2016-08-02
CPC Classification: A61B,A61M,A61P

Claim Text:
1. In a system providing treatment of cardiac arrest by withdrawing blood from a patient's or an animal's circulatory system during the cardiac arrest and introducing at least modified blood containing the withdrawn blood to which at least one substance has been added to provide whole body reperfusion of the circulatory system with the modified blood during the treatment of cardiac arrest comprising blood analysis means, for connection during the treatment of the cardiac arrest to the blood withdrawn from the circulatory system, for determining during the treatment of the cardiac arrest, a plurality of parameters of the blood including at least pO2, pCO2, and pH representing a current condition of the patient or animal during treatment of the cardiac arrest and an output representing the determination during the treatment of the cardiac arrest, storage means for storing during the treatment of the cardiac arrest at least two substances from which the at least one substance is selected for the treatment of the cardiac arrest, means for selecting during the treatment of the cardiac arrest, based on the analysis, a type and quantity of the at least one substance from the storage means which is added to the withdrawn blood to form the modified blood, which upon introduction into the circulatory system during the treatment of the cardiac arrest lessens or prevents ischemic tissue damage and means for introducing during the treatment of the cardiac arrest at least the modified blood into the circulatory system which provides the whole body reperfusion of the circulatory system during the treatment of the cardiac arrest which lessens or prevents the ischemic tissue damage during the treatment of the cardiac arrest, the method comprising: withdrawing the blood from the circulatory system during the cardiac arrest; analyzing the blood withdrawn from the circulatory system with the blood analysis means during the cardiac arrest and determining during the treatment of the cardiac arrest the plurality of parameters of the blood including at least pO selecting, based on the determination of at least the pO2, the pCO2 and the pH, during the treatment of the cardiac arrest, a type and quantity of the at least one substance from the stored substances which is added to the blood to form the modified blood which upon introduction of the modified blood into the circulatory system during the treatment of the cardiac arrest lessens or prevents ischemic tissue damage; and introducing at least the modified blood into the circulatory system during the treatment of the cardiac arrest which provides the whole body reperfusion of the circulatory system with the modified blood to treat the cardiac arrest which lessens or prevents ischemic tissue damage during the treatment of the cardiac arrest.